All In Biotech

Drug Trial Radar · NCT02922686

Penicillin for the Emergency Department Outpatient Treatment of CELLulitis

Oral Flucloxacillin Alone Versus Flucloxacillin and Phenoxymethylpenicillin for the Emergency Department Outpatient Treatment of Cellulitis: a Non-inferiority Randomised Controlled Trial.

Last checked: Nov 19, 2026Latest source record: Oct 4, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 414 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

414

Planned (sponsor's estimate)

Start

Dec 2016

Primary completion

Dec 2019

Study completion Dec 2019

Sponsor

Lead sponsor
Royal College of Surgeons, IrelandAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Health Research Board, Ireland
First posted
Oct 4, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 16 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main objective of this study is to investigate the non-inferiority of oral flucloxacillin alone compared with a combination of oral flucloxacillin and phenoxymethylpenicillin for the emergency department directed outpatient treatment of cellulitis, wound infections and abscesses, recently renamed by the Food and Drug Administration (FDA) as acute bacterial skin and skin structure infections (ABSSSIs). Half of the trial participants will receive flucloxacillin and placebo in combination, and the remaining half will be treated will flucloxacillin and phenoxymethylpenicillin. In a secondary objective the trial aims to measure adherence and persistence of trial patients with outpatient antibiotic therapy. In addition a within-trial evaluation of the cost per quality adjusted life year (QALY) gained from the use of oral flucloxacillin compared with combination therapy from the perspective of the health-care payer (direct costs) the patient and government. Finally the study will externally validate the Extremity Soft Tissue Infection-score, a Health Related Quality of Life (HRQL) questionnaire designed to quantify the impact of cellulitis, wound infections and abscesses on patient HRQL in clinical trials.

Conditions

  • Cellulitis
  • Wound Infection
  • Abscess

Interventions

  • FlucloxacillinDrug

    One flucloxacillin capsule of 500mg strength taken four times daily for 7 days

  • PhenoxymethylpenicillinDrug

    One capsule of phenoxymethylpenicillin of 500 mg strength taken four times daily for 7 days

  • Placebo (for phenoxymethylpenicillin)Drug

    Over-encapsulation of phenoxymethylpenicillin will be performed by the manufacturer of the investigational medicinal products such that placebo and active phenoxymethylpenicillin are identical in size, shape, colour and smell, and are packaged in identical bottles

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Investigator-determined clinical responseTime frame: Test Of Cure visit (Day 14-21 post randomization)

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Department of Emergency Medicine, Connolly Hospital,

    Blanchardstown, Dublin, Ireland

  • Department of Emergency Medicine, Mater Misericordiae University Hospital

    Dublin, Dublin, Ireland

  • Beaumont Hospital,

    Dublin, Dublin, Ireland

  • Department of Emergency Medicine, Mercy University Cork

    Cork, Greenville Place, Ireland

  • Department of Emergency Medicine, Cork University Hospital

    Cork, Wilton, Ireland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.